<DOC>
	<DOCNO>NCT00995618</DOCNO>
	<brief_summary>This randomize , double-blind , 3-period crossover phase 2 study patient document hyperuricemia evaluate effect tranilast febuxostat pharmacokinetics ( PK ) pharmacodynamics ( PD ) evaluate effect febuxostat tranilast PK PD measure reduction serum uric acid level .</brief_summary>
	<brief_title>Study Tranilast Alone Combination With Febuxostat Patients With Hyperuricemia</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<mesh_term>Tranilast</mesh_term>
	<criteria>Male female , age 18 70 Subjects hyperuricemia otherwise healthy Pregnant nursing Known history gout Clinically significant infection Screening Known sensitivity tranilast febuxostat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Gout</keyword>
	<keyword>Hyperuricemia</keyword>
</DOC>